Holen Sie sich die Stockscreener-App
5.46
1.68%
0.09
Handel nachbörslich:
5.47
0.010
+0.18%
Schlusskurs vom Vortag:
$5.37
Offen:
$5.47
24-Stunden-Volumen:
451.72K
Relative Volume:
0.33
Marktkapitalisierung:
$198.30M
Einnahmen:
$317.00K
Nettoeinkommen (Verlust:
$-53.47M
KGV:
-2.8889
EPS:
-1.89
Netto-Cashflow:
$-49.31M
1W Leistung:
-2.50%
1M Leistung:
+59.18%
6M Leistung:
+268.92%
1J Leistung:
+336.80%
1-Tages-Spanne:
$5.305
$5.53
1-Wochen-Bereich:
$5.165
$6.35
52-Wochen-Spanne:
$1.10
$6.35
Immuneering Corp Stock (IMRX) Company Profile
Firmenname
Immuneering Corp
Sektor
Branche
Telefon
617-500-8080
Adresse
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE
Vergleichen Sie IMRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IMRX
Immuneering Corp
|
5.46 | 255.46M | 317.00K | -53.47M | -49.31M | -1.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Immuneering Corp Stock (IMRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-13 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2024-03-15 | Herabstufung | Jefferies | Buy → Hold |
| 2024-03-15 | Bestätigt | Needham | Buy |
| 2024-03-15 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-01 | Eingeleitet | Needham | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2023-04-19 | Hochstufung | Mizuho | Neutral → Buy |
| 2023-04-19 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-03-30 | Eingeleitet | Mizuho | Neutral |
| 2023-02-03 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-07-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2022-04-01 | Eingeleitet | Oppenheimer | Outperform |
| 2022-01-07 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Immuneering Corp Aktie (IMRX) Neueste Nachrichten
Can Immuneering Corporation ride the EV waveJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - khodrobank.com
Immuneering Corporation (IMRX) files for up to 9.18M share offering by selling stockholders - StreetInsider
Custom watchlist performance reports with Immuneering Corporation2025 Geopolitical Influence & Daily Chart Pattern Signals - Newser
Buyback Watch: Can Immuneering Corporation deliver consistent dividends2025 Growth vs Value & Verified Swing Trading Watchlist - khodrobank.com
Can a trend reversal in Immuneering Corporation lead to recoveryJuly 2025 WrapUp & AI Forecast for Swing Trade Picks - Newser
Order flow analysis tools used on Immuneering CorporationWeekly Gains Summary & High Conviction Trade Alerts - Newser
How hedge fund analytics apply to Immuneering Corporation stockMarket Movement Recap & Daily Profit Focused Stock Screening - Newser
Building trade automation scripts for Immuneering CorporationBreakout Watch & Safe Swing Trade Setups - Newser
What momentum shifts mean for Immuneering CorporationRisk Management & Technical Pattern Alert System - Newser
Is Immuneering Corporation a cyclical or defensive stockShort Setup & Growth Oriented Trading Recommendations - khodrobank.com
Understanding Immuneering Corporation’s price movementJuly 2025 Market Mood & Technical Pattern Recognition Alerts - Newser
Does Immuneering Corporation show high probability of reboundShare Buyback & Daily Oversold Bounce Ideas - Newser
Can Immuneering Corporation recover in the next quarterJuly 2025 Institutional & Fast Momentum Stock Entry Tips - Newser
Tick level data insight on Immuneering Corporation volatilityCPI Data & Fast Gaining Stock Strategy Reports - Newser
What machine learning models say about Immuneering CorporationOil Prices & Real-Time Stock Entry Alerts - Newser
Is Immuneering Corporation stock entering bullish territoryQuarterly Performance Summary & Fast Momentum Entry Tips - Newser
Can Immuneering Corporation expand into new markets2025 Breakouts & Breakdowns & Smart Investment Allocation Tips - kpenews.com
Leading vs lagging indicators on Immuneering Corporation performance2025 Technical Overview & Stepwise Trade Execution Plans - Newser
Published on: 2025-08-29 00:05:44 - Newser
Live market analysis of Immuneering CorporationTake Profit & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-28 12:45:47 - Newser
Using Python tools to backtest Immuneering Corporation strategiesPortfolio Update Report & Verified Momentum Stock Alerts - Newser
Immuneering Corporation stock prediction for this weekJuly 2025 Retail & AI Forecasted Entry and Exit Points - Newser
How Immuneering’s financial strategy fuels scientific breakthroughs - BioXconomy
Immuneering (NASDAQ:IMRX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Finanzdaten der Immuneering Corp-Aktie (IMRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Immuneering Corp-Aktie (IMRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HAUSMAN DIANA | Director |
Jul 02 '25 |
Buy |
3.60 |
2,500 |
8,989 |
2,500 |
| Neufeld Leah R | CHIEF PEOPLE OFFICER |
Jul 02 '25 |
Buy |
3.57 |
700 |
2,499 |
10,729 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jul 02 '25 |
Buy |
3.53 |
7,015 |
24,792 |
2,312,852 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jul 01 '25 |
Buy |
3.38 |
2,985 |
10,087 |
2,305,837 |
| Schall Thomas J. | Director |
Jun 27 '25 |
Buy |
3.66 |
9,500 |
34,788 |
52,885 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER |
Jun 20 '25 |
Buy |
2.70 |
7,415 |
20,020 |
353,311 |
| Hall Brett Matthew | CHIEF SCIENTIFIC OFFICER |
Jun 23 '25 |
Buy |
2.43 |
6,007 |
14,596 |
359,318 |
| Brakewood Harold Eugene | Chief Business Officer |
Jun 20 '25 |
Buy |
2.53 |
1,900 |
4,804 |
5,800 |
| Feinberg Peter | Director |
Jun 18 '25 |
Buy |
2.53 |
25,000 |
63,188 |
136,766 |
| Zeskind Benjamin J. | PRESIDENT AND CEO |
Jun 18 '25 |
Buy |
2.39 |
21,000 |
50,144 |
2,302,852 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):